Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Brain tumor-derived extracellular vesicles as carriers of disease markers: Molecular chaperones and micrornas

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      MDPI AG
    • Publication Date:
      2020
    • Collection:
      UMB Digital Archive (University of Maryland, Baltimore)
    • Abstract:
      Primary and metastatic brain tumors are usually serious conditions with poor prognosis, which reveal the urgent need of developing rapid diagnostic tools and efficacious treatments. To achieve these objectives, progress must be made in the understanding of brain tumor biology, for example, how they resist natural defenses and therapeutic intervention. One resistance mechanism involves extracellular vesicles that are released by tumors to meet target cells nearby or distant via circulation and reprogram them by introducing their cargo. This consists of different molecules among which are microRNAs (miRNAs) and molecular chaperones, the focus of this article. miRNAs modify target cells in the immune system to avoid antitumor reaction and chaperones are key survival molecules for the tumor cell. Extracellular vesicles cargo reflects the composition and metabolism of the original tumor cell; therefore, it is a source of markers, including the miRNAs and chaperones discussed in this article, with potential diagnostic and prognostic value. This and their relatively easy availability by minimally invasive procedures (e.g., drawing venous blood) illustrate the potential of extracellular vesicles as useful materials to manage brain tumor patients. Furthermore, understanding extracellular vesicles circulation and interaction with target cells will provide the basis for using this vesicle for delivering therapeutic compounds to selected tumor cells. © 2020 by the authors. ; This work was funded in part by the Italian National Operational Programme (PON) «Imprese e Competitività» 2014-2020 FESR, grant awarded by the Italian Ministry of Economic Development to the project titled «Gestione di un servizio integrato multicentrico di diagnostica e terapia personalizzata in oncologia» (Project code: F/090012/01-02/X36). A.J.L.M and E.C.d.M. were partially supported by IMET and IEMEST. This is IMET contribution number IMET 20-019. ; https://doi.org/10.3390/app10196961
    • Relation:
      Applied Sciences (Switzerland); http://hdl.handle.net/10713/13946
    • Accession Number:
      10.3390/app10196961
    • Online Access:
      http://hdl.handle.net/10713/13946
      https://doi.org/10.3390/app10196961
    • Accession Number:
      edsbas.DE9FC375